Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Curr Opin Nephrol Hypertens
    January 2018
  1. HAAS M
    Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Curr Opin Nephrol Hypertens. 2018 Jan 2. doi: 10.1097/MNH.0000000000000398.
    >> Share

    December 2017
  2. RAO M, Jaber BL, Balakrishnan VS
    Chronic kidney disease and acquired mitochondrial myopathy.
    Curr Opin Nephrol Hypertens. 2017 Dec 20. doi: 10.1097/MNH.0000000000000393.
    >> Share

    November 2017
  3. KRAUT JA, Madias NE
    Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
    Curr Opin Nephrol Hypertens. 2017 Nov 14. doi: 10.1097/MNH.0000000000000386.
    >> Share

  4. SCHMIDT RJ
    Incorporating supportive care into the hemodialysis unit.
    Curr Opin Nephrol Hypertens. 2017;26:530-536.
    >> Share

    October 2017
  5. WALTHER CP, Chandra A, Navaneethan SD
    Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Oct 16. doi: 10.1097/MNH.0000000000000375.
    >> Share

    September 2017
  6. GOLPER TA
    Incremental dialysis: review of recent literature.
    Curr Opin Nephrol Hypertens. 2017 Sep 11. doi: 10.1097/MNH.0000000000000362.
    >> Share

  7. SY J, Johansen KL
    The impact of frailty on outcomes in dialysis.
    Curr Opin Nephrol Hypertens. 2017 Sep 9. doi: 10.1097/MNH.0000000000000364.
    >> Share

    August 2017
  8. GEORGIANOS PI, Agarwal R
    Blood pressure in hemodialysis: targets?
    Curr Opin Nephrol Hypertens. 2017 Aug 21. doi: 10.1097/MNH.0000000000000359.
    >> Share

  9. WONNACOTT A, Bowen T, Fraser DJ
    MicroRNAs as biomarkers in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Aug 12. doi: 10.1097/MNH.0000000000000356.
    >> Share

    March 2017
  10. HSU RK, Powe NR
    Recent trends in the prevalence of chronic kidney disease: not the same old song.
    Curr Opin Nephrol Hypertens. 2017 Mar 17. doi: 10.1097/MNH.0000000000000315.
    >> Share

  11. COLLISTER D, Rigatto C, Tangri N
    Anemia management in chronic kidney disease and dialysis: a narrative review.
    Curr Opin Nephrol Hypertens. 2017 Mar 16. doi: 10.1097/MNH.0000000000000317.
    >> Share

    February 2017
  12. DAVIS JL, Davison SN
    Hard choices, better outcomes: a review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management.
    Curr Opin Nephrol Hypertens. 2017 Feb 16. doi: 10.1097/MNH.0000000000000321.
    >> Share

  13. COWAN AC, Gharib EG, Weir MA
    Advances in the management of hyperkalemia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 15. doi: 10.1097/MNH.0000000000000320.
    >> Share

  14. MOORTHI RN, Avin KG
    Clinical relevance of sarcopenia in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000318.
    >> Share

  15. RUZICKA M, Hiremath S
    Intensive blood pressure lowering in chronic kidney disease: the time has come.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000316.
    >> Share

    November 2016
  16. GORDON CE, Nader C
    Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    October 2016
  17. DHAYBI OA, Bakris G
    Mineralocorticoid antagonists in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    September 2016
  18. MAVRAKANAS TA, Charytan DM
    Cardiovascular complications in chronic dialysis patients.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  19. CUNHA CB, D'Agata EM
    Implementing an antimicrobial stewardship program in out-patient dialysis units.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  20. TUMMALAPALLI L, Nadkarni GN, Coca SG
    Biomarkers for predicting outcomes in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    August 2016
  21. LEE MB, Bargman JM
    Myths in peritoneal dialysis.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  22. KALRA PA, Bhandari S
    Safety of intravenous iron use in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  23. WOJCIECHOWSKI D, Vincenti F
    Current status of costimulatory blockade in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  24. MATSUSHITA K, Ballew SH, Coresh J
    Cardiovascular risk prediction in people with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  25. AHMAD S, Bromberg JS
    Current status of the microbiome in renal transplantation.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  26. FRASER SD, Taal MW
    Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

    May 2016
  27. GINSBERG C, Ix JH
    Nicotinamide and phosphate homeostasis in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2016.
    >> Share

  28. LYTVYN Y, Bjornstad P, Pun N, Cherney DZ, et al
    New and old agents in the management of diabetic nephropathy.
    Curr Opin Nephrol Hypertens. 2016;25:232-9.
    >> Share

    November 2015
  29. TOWNSEND RR, Reese PP, Lim MA
    Should living kidney donors with hypertension be considered for organ donation?
    Curr Opin Nephrol Hypertens. 2015;24:594-601.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016